1) Chang B, et al:Surveillance of Group B streptococcal toxic shock-like syndrome in nonpregnant adults and characterization of the strains in Japan. Jpn J Infect Dis 59(3):182-185, 2006
2) Ikebe T, et al:Surveillance of severe invasive group G streptococci infections and molecular typing of the isolates in Japan. Epidemiol Infect 132(1):145-149, 2004
3) Hashikawa S, et al:Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 42(1):186-192, 2004
4) 宇田川秀夫・他:A群溶連菌の激烈な敗血症により双胎胎児と母親が突然死した症例.感染症学雑誌67(12):1219-1222,1993
5) Stevens DL, et al:Reappearance of scarlet fever toxin A among streptococci in Rocky Mountain West;severe group A streptococcal infections associated with a toxic shock-like syndrome. N Engl J Med 321(1):1-7, 1989
6) Stevens DL:Invasive group A streptococcus infections. Clin Infect Dis 14(1):2-13, 1992
7) Stevens DL:Streptococcal infections of skin and soft tissue. In Atlas of Infectious Diseases(Stevens DL, Mandell GL, ed). 3.1-3.11, Churchill Livingstone, New York, 1995
database. http://www.cdc.gov/ncidod/biotech/strep/strepindex.html
9) Horstmann RD, et al:Antiphagocytic activity of streptococcal M protein;selective binding of complement control protein factor H. Proc Natl Acad Sci USA 85(5):1657-1661, 1988
10) Fischetti VA:Streptococcal M protein;molecular design and biological behavior. Clin Microbiol Rev 2(3):285-300, 1989
-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953-958, 1996
isolated from common and severe invasive infections in Japan, 1990-5;implication of the T3 serotype strain-expansion in TSLS. Epidemiol Infect 119(1):41-48, 1997
isolates from streptococcal toxic shock-like syndrome(TSLS)patients in Japan. Epidemiol Infect 130(3):569-572, 2003
isolates from patients with severe invasive streptococcal infections in Japan, 2001-2005. Epidemiol Infect 135(7):1227-1229, 2007
15) 清水方可:劇症型A群連鎖球菌感染症の病態と治療.日本医事新報4081:92,2002
16) Stevens DL, et al:Invasive group A streptococcal infection;new concepts in antibiotic treatment. Int J Antimicrob Agent 4(4):297-301, 1994
17) Burry W, et al:Intravenous immunogloburin therapy for toxic shock syndrome. JAMA 267(24):3315-3316, 1992